Victory Capital Management Inc Shattuck Labs, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$4.22 - $8.89 $23,463 - $49,428	-5,560 Reduced 2.73%	198,010 $844,000
Q4 2021 Feb 07, 2022	BUY	$8.36 - $21.08 $463,394 - $1.17 Million	55,430 Added 37.42%	203,570 $1.73 Million
Q3 2021 Nov 02, 2021	BUY	$17.57 - $28.95 $1.02 Million - $1.67 Million	57,840 Added 64.05%	148,140 $3.02 Million
Q2 2021 Aug 03, 2021	BUY	$24.14 - $37.68 $777,066 - $1.21 Million	32,190 Added 55.39%	90,300 $2.62 Million
Q1 2021 May 04, 2021	SELL	$27.92 - $52.5 $558,400 - $1.05 Million	-20,000 Reduced 25.6%	58,110 $1.7 Million
Q4 2020 Feb 01, 2021	BUY	$19.0 - $57.61 $1.48 Million - $4.5 Million	78,110 New	78,110 $4.09 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.